VANGUARD GROUP INC - CONTEXT THERAPEUTICS INC ownership

CONTEXT THERAPEUTICS INC's ticker is and the CUSIP is 21077P108. A total of 23 filers reported holding CONTEXT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CONTEXT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$896,171
-2.5%
593,491
+3.3%
0.00%
Q2 2023$919,520
+185.2%
574,700
+0.2%
0.00%
Q1 2023$322,365
-22.8%
573,400
-10.5%
0.00%
Q4 2022$417,650
-41.3%
640,863
+0.0%
0.00%
Q3 2022$711,000
-46.7%
640,699
+1.9%
0.00%
Q2 2022$1,333,000
+159.8%
628,979
+166.2%
0.00%
Q1 2022$513,000
-10.2%
236,279
+10.1%
0.00%
Q4 2021$571,000214,6790.00%
Other shareholders
CONTEXT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 725,951$1,096,1861.29%
Affinity Asset Advisors, LLC 328,817$496,5140.14%
Aspire Wealth Management Corp 10,000$15,1000.01%
UBS OCONNOR LLC 295,700$446,5070.01%
Clear Harbor Asset Management, LLC 36,000$54,3600.01%
Mill Creek Capital Advisors, LLC 104,631$157,9930.01%
SHEETS SMITH WEALTH MANAGEMENT 20,000$30,2000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 105,809$159,7720.00%
XTX Topco Ltd 13,259$20,0210.00%
GEODE CAPITAL MANAGEMENT, LLC 97,240$146,9080.00%
View complete list of CONTEXT THERAPEUTICS INC shareholders